Personalis Inc. (PSNL)
NASDAQ: PSNL
· Real-Time Price · USD
4.82
0.19 (4.10%)
At close: Jun 02, 2025, 3:59 PM
4.85
0.62%
After-hours: Jun 02, 2025, 05:02 PM EDT
4.10% (1D)
| Bid | 4.74 |
| Market Cap | 425.73M |
| Revenue (ttm) | 85.69M |
| Net Income (ttm) | -84.07M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -3.74 |
| Forward PE | -4.98 |
| Analyst | Strong Buy |
| Ask | 5.1 |
| Volume | 653,357 |
| Avg. Volume (20D) | 788,003 |
| Open | 4.77 |
| Previous Close | 4.63 |
| Day's Range | 4.63 - 4.99 |
| 52-Week Range | 1.14 - 7.20 |
| Beta | 1.84 |
About PSNL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PSNL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PSNL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+21%
Personalis shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+9.32%
Personalis shares are trading higher after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.
